HEALTH-SOVEREIGNTY & MEDTECH DESK  ·  DISPATCH

AfricInvest's Transform Health Fund (THF), a blended-finance vehicle co-managed with the Health Finance Coalition, invested US$8.5 million as a senior secured loan facility in Promamec, a Moroccan medical equipment and consumables supplier with integrated local production and assembly capabilities. The deal, announced 22 December 2025, is the logic this fund exists to execute: DFC made an anchor equity investment of up to US$10 million into THF — a fund targeting US$100 million — specifically to back medical device manufacturing, pharma supply chain, primary care, and digital health small and medium-sized enterprises (SMEs).

This is Global-South manufacturing sovereignty in its plainest instrument form: a development-finance institution does not lend to the device maker directly. It anchors a fund manager, which then originates and structures debt to a specific company. The DFC's US$10 million check is not the US$8.5 million that reached Promamec — it is the capital that made the fund credible enough to raise toward its US$100 million target and to write that loan. Tracing the money this way is the point: a single DFC anchor investment is designed to originate a pipeline of device-manufacturing loans across the Global South, of which Promamec is the first disclosed deal.

Promamec's local production and assembly capacity is what makes this a manufacturing-sovereignty story rather than an ordinary trade-finance loan. The company combines distribution with local production, explicitly reducing Morocco's reliance on imported medical equipment in the categories it manufactures. A senior secured loan — debt, not equity — is a comparatively conservative instrument for this kind of deal, consistent with a fund still building its track record rather than taking founder-level risk this early.

What is not disclosed is as telling as what is: neither the fund's other pipeline deals nor Promamec's specific production volumes appear in the source record. This is one loan, from one blended-finance vehicle, to one Moroccan manufacturer — evidence of a mechanism working as designed, not yet evidence that it scales.

A development bank's anchor check rarely touches the factory floor directly. It touches the fund that touches the loan that touches the floor — and that distance is the instrument, not an accident of it.

— Capital Statecraft Intelligence · Health-Sovereignty & MedTech Desk

Primary source(s): AfricInvest (fund manager press release)